Journal of Capital Medical University ›› 2020, Vol. 41 ›› Issue (5): 756-762.doi: 10.3969/j.issn.1006-7795.2020.05.007

• National Science Fund for Distinguished Young Science Winner • Previous Articles     Next Articles

An explorers of Alzheimer's disease——Professor Zhang Chen

Zhang Chen   

  1. School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China
  • Received:2020-09-09 Online:2020-10-21 Published:2020-10-26

Abstract: Dr. Zhang Chen, Professor and Dean, School of Basic Medical Sciences, Capital Medical University. As the most common neurodegenerative disease, the early causes of Alzheimer's disease (AD) remain unclear. Dr. Zhang has long been devoted himself to exploring the early neurological pathogenesis of AD. He found that short-term plasticity abnormality is an early pathological event in AD cases, and this deficit is caused by intracellular ryanodine receptor deficiency. Furthermore, using the two-photon method to study neural circuit activities on awake animals, he found that the prefrontal cortex incapable of encoding short-term memory is an earlier pathological event of AD compared with short-term plasticity deficits. Moreover, Dr. Zhang has identified several novel candidates (PTPRO, ABHD6 and others) functioning in the process of synapse formation and synaptic transmission, providing potential candidates for AD treatments.

Key words: Alzheimer's disease, synaptic dysfunction, new synaptic regulatory molecules

CLC Number: